Search Results (95)

MatchTypeWhy
LI, ANGPerson Why?
Complement activation in thrombotic microangiopathies.Academic Article Why?
Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA).Academic Article Why?
Plasma exchange therapy for thrombotic microangiopathies.Academic Article Why?
Thrombotic microangiopathies: multimers, metalloprotease, and beyond.Academic Article Why?
Thrombotic microangiopathy associated with Valproic acid toxicity.Academic Article Why?
Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.Academic Article Why?
Diffuse alveolar hemorrhage: An underreported complication of transplant associated thrombotic microangiopathy.Academic Article Why?
Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients.Academic Article Why?
Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy.Academic Article Why?
Incidence and Risk Factors of Transplantation-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis.Academic Article Why?
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy.Academic Article Why?
Prognostic Biomarkers for Thrombotic Microangiopathy after Acute Graft-versus-Host Disease: A Nested Case-Control Study.Academic Article Why?
Purtscher-like retinopathy: A rare presentation of hematopoietic stem cell transplant-associated thrombotic microangiopathy.Academic Article Why?
The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.Academic Article Why?
Per Page    Page  of 7last Nextnext
Prev
Search Criteria
  • Thrombotic Microangiopathy
Filter by Type
_
Click "Why?" to see why an item matched the search.